1. Home
  2. RNST vs RCUS Comparison

RNST vs RCUS Comparison

Compare RNST & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

N/A

Current Price

$36.06

Market Cap

3.5B

Sector

Finance

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$23.05

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNST
RCUS
Founded
1904
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
RNST
RCUS
Price
$36.06
$23.05
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$42.25
$29.20
AVG Volume (30 Days)
647.5K
1.2M
Earning Date
04-27-2026
05-28-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$31.83
N/A
Revenue Next Year
$4.58
$57.34
P/E Ratio
$17.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.26
$6.79
52 Week High
$42.11
$26.40

Technical Indicators

Market Signals
Indicator
RNST
RCUS
Relative Strength Index (RSI) 34.99 54.85
Support Level $35.45 $20.35
Resistance Level $37.99 $24.45
Average True Range (ATR) 1.26 1.49
MACD -0.44 0.40
Stochastic Oscillator 14.54 69.58

Price Performance

Historical Comparison
RNST
RCUS

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: